Doctors question FDA approval of Gilead’s COVID-19 treatment and say it has limited benefits

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

The FDA’s decision to grant a full approval to Gilead’s remdesivir is raising questions about the broader value of a drug that has been praised for being “first” but may only provide limited clinical benefits. $GILD

The Food and Drug Administration’s decision to grant a full approval to Gilead Sciences Inc.’s remdesivir is raising questions about the broader value of a drug that has been praised for being “first” but may only provide limited clinical benefits.

See also: Coronavirus update: U.S. death toll tops 223,000; rural hospitals are filling and the Dakotas lead the nation by new infections Yet other studies, including two trials in China and one conducted by the World Health Organization, have found little benefit in Veklury. The WHO’s Solidarity trial is a randomized, open-label study evaluating four antiviral drugs, including Veklury, in 11,330 hospitalized patients around the world; it found that the drugs had “little or no effect” on mortality, the need for ventilation or duration of hospital stay, according to interim findings published Oct.

Dr. Peter Bach, an epidemiologist and director of Memorial Sloan Kettering Cancer Center’s Center for Health Policy and Outcomes, called the approval “astonishing” in a tweet, before criticizing the use of clinical trials that either lacked a control arm or blinding in the approval. “An entirely negative real-world [randomized controlled trial] was larger than these put together,” Bach tweeted.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Not affordable on scale of a pandemic. Or epidemic. Boutique drug for purpose of enriching a few execs

All about the money...duh

VOTE FOR: DONALD TRUMP.

The FDA is playing politics with Covid.! Biden should dissolve this aging dinosaur long passed its usefulness.

Well... just fyi... decreased length of stay is *gold* to a hospital. Allow me to educate... they get paid a fixed amount per diagnosis therfore shorter stay is a *major* cost savings. Decreased mortality is great for us humans but hospitals are worried about money.

Don owns stock in the company. factor that in the free ads he made.

ProsperBryson lol

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead shares rise after United States approves remdesivir as COVID-19 drugShares of Gilead Sciences Inc rose 6% on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the United States. Very funny.. Reading Gilead and USA in one sentence always feels creepy. I always have to think of thehandmaidstale Love to hear the story behind that company name-choice. Did they read the handmaids tale and decided 'yea Gilead, what a perfect world of enslaved people, that's what we want. Lets use that as our drug-company name' Handmaid's Tale: Pub. 1985 Gilead drugcompany: 1987
Source: Reuters - 🏆 2. / 97 Read more »

Gilead's remdesivir gets U.S. FDA approval for use in hospitalized COVID-19 patientsGilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs Didn’t I read a week ago it wasn’t effective?
Source: YahooNews - 🏆 380. / 59 Read more »

FDA Approves Remdesivir to Treat COVID-19The pharmaceutical company Gilead Sciences announced that the FDA has approved the antiviral drug remdesivir for treating COVID-19, the company said Thursday in a news release. What you need to know:
Source: WebMD - 🏆 709. / 51 Read more »

Mexico will not follow FDA in approving Gilead's COVID-19 drugMexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug remdesivir for use in COVID-19 patients, a top Mexican health official said on Friday. Smart. I would not trust anything coming from the Trump admin Welp, that should be a red flag for Americans. I’m not taking anything until Dr. Fauci says it’s safe. I trust him, none of Trump’s unqualified sycophants.
Source: Reuters - 🏆 2. / 97 Read more »

FDA approves remdesivir as first coronavirus drugToday the FDA approved Gilead's coronavirus drug remdesivir — making it the only Covid-19 treatment to win full approval from U.S. regulators Who profits? Pity it doesn't work The new hydroxychloroquine? Can we trade the 60 million doses of hydroxychloroquine from the Navarro National Stockpile for 100 doses of remdesivir?
Source: politico - 🏆 381. / 59 Read more »

U.S. New Coronavirus-Case Count Breaks 70,000, Highest Since JulyThe daily number of Covid-19 cases reported in the U.S. rose to 71,671 on Thursday, the most in a single day since July 24 and the third-highest single-day total overall. Or maybe everyone could just wear masks, cases will go down and we can focus on building back the economy... Yet deemed ineffective by healthcare professionals on the actual front line of the COVID19 war TrumpVirus BidenHarris2020 GREAT NEWS!
Source: WSJ - 🏆 98. / 63 Read more »